Sáez-Llorens, X. Et Al. 2024. Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus vaccine in infants 6-7 months of age: a phase 1/2 randomized trial.. The Journal of infectious diseases , vol.229 , 95-107.

Sáez-Llorens, X., Norero, X., Mussi-Pinhata, M. M., Luciani, K., Salamanca de la Cueva, I., Díez-Domingo, J., ... Lopez-Medina, E.(2024). Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus vaccine in infants 6-7 months of age: a phase 1/2 randomized trial.. The Journal of infectious diseases , vol.229, 95-107.

Sáez-Llorens, Xavier Et Al. "Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus vaccine in infants 6-7 months of age: a phase 1/2 randomized trial.," The Journal of infectious diseases , vol.229, 95-107, 2024

Sáez-Llorens, Xavier Et Al. "Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus vaccine in infants 6-7 months of age: a phase 1/2 randomized trial.." The Journal of infectious diseases , vol.229, pp.95-107, 2024

Sáez-Llorens, X. Et Al. (2024) . "Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus vaccine in infants 6-7 months of age: a phase 1/2 randomized trial.." The Journal of infectious diseases , vol.229, pp.95-107.

@article{article, author={Xavier Sáez-Llorens Et Al. }, title={Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus vaccine in infants 6-7 months of age: a phase 1/2 randomized trial.}, journal={The Journal of infectious diseases}, year=2024, pages={95-107} }